Company news
MannKind Corporation news in 2021
MannKind Corporation's news releases, calls and decks from 2021, newest first.
MannKind Corporation to Participate in the Lytham Partners Winter 2021 Investor Conference
December 5, 2021
MannKind Corporation Reports 2021 Third Quarter Financial Results
November 8, 2021
Mannkind Corporation Closes Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gross Proceeds
November 8, 2021
MannKind Presents Data at 21st Annual Diabetes Technology Meeting
November 4, 2021
MannKind Corporation to Hold 2021 Third Quarter Financial Results Conference Call on November 9, 2021
November 1, 2021
Progress Update on Tyvaso DPI™ New Drug Application
October 17, 2021
MannKind Announces First Patient Enrolled In Inhale-1 Study Of Afrezza® In Pediatric Population
October 3, 2021
Mannkind Corporation Announces Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gross Proceeds
September 28, 2021
MannKind Corporation to Participate at Lytham Partners Fall 2021 Investor Conference
September 27, 2021
Mannkind Corporation Participating at Upcoming Conferences
September 14, 2021
MannKind Corporation to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
September 6, 2021
United Therapeutics to Present Tyvaso DPI™ BREEZE Clinical Data at the European Respiratory Society International Congress 2021
August 23, 2021
MannKind Corporation Reports 2021 Second Quarter Financial Results
August 10, 2021
MannKind Partners With NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI™ (aviptadil) Based On The Technosphere® Platform
August 3, 2021
MannKind Corporation to Hold 2021 Second Quarter Financial Results Conference Call on August 11, 2021
August 3, 2021
MannKind Corporation to Participate in the BTIG Virtual Biotechnology Conference 2021
August 2, 2021
Policy Change Allows Approval For Medicare Patients Living With Diabetes To Use Both Afrezza® And Continuous Glucose Monitoring Devices Beginning July 18
June 27, 2021
MannKind Presents Two Posters At American Diabetes Association's Virtual 81st Scientific Sessions, June 25-29
June 24, 2021
United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application For Priority Review
June 15, 2021
MannKind And United Therapeutics Achieve A Major Milestone In The Development Of Tyvaso DPI™ With New Drug Application Acceptance From The FDA
June 15, 2021
MannKind and Thirona Bio Join Forces to Evaluate Potential Inhaled Therapy for Fibrotic Lung Diseases
June 9, 2021
MannKind Corporation at the Lytham Partners Summer 2021 Investor Conference
June 7, 2021
MannKind Announces Data Presentation At 14th International Conference On Advanced Technologies & Treatments For Diabetes (ATTD 2021) To Be Held Virtually June 2-5
June 2, 2021
MannKind Announces Partnership With Type 1 Diabetes IndyCar Driver Conor Daly
May 12, 2021
MannKind Corporation Reports 2021 First Quarter Financial Results
May 11, 2021
MannKind Corporation to Participate in 2021 RBC Capital Markets Global Healthcare Conference
May 10, 2021
MannKind Corporation to Hold 2021 First Quarter Financial Results Conference Call on May 12, 2021
May 4, 2021
MannKind Reduces Legacy Debt by Approximately $49.5 Million and Restructures Remaining Obligations, including Extended Maturity, Lower Interest Rates and Increased Third Tranche
April 25, 2021
Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI™ With New Drug Application Submitted to the FDA
April 18, 2021
MannKind Announces Closing of Initial Purchasers’ Option to Purchase Additional Convertible Senior Notes
March 15, 2021
MannKind to Participate in 2022 Medicare Part D Senior Savings Model to Make Insulin More Affordable for Seniors
March 14, 2021
MannKind Corporation to Participate in Oppenheimer's 31st Annual Healthcare Conference
March 9, 2021
MannKind Corporation to Participate in H.C. Wainwright Global Life Sciences Conference
March 1, 2021
MannKind Corporation Prices Upsized $200.0 Million Convertible Senior Notes Offering
March 1, 2021
MannKind Corporation Announces Proposed Private Placement of Convertible Senior Notes
February 28, 2021
MannKind Corporation Reports 2020 Fourth Quarter and Full Year Financial Results
February 24, 2021
MannKind Corporation to Participate in 2021 SVB Leerink Global Healthcare Conference
February 17, 2021
MannKind Corporation to Hold 2020 Fourth Quarter and Full Year Financial Results Conference Call on February 25, 2021
February 17, 2021
MannKind Corporation to Participate in H.C. Wainwright Bioconnect 2021 Conference
January 3, 2021